London · Pre-Seed–Series A · 2 people tracked
Find your way into re.Mind Capital
4,075 people in our graph share verified history with the re.Mind Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
An early-stage venture capital firm focused exclusively on investing in mental health, brain health, and human flourishing companies.
Source: firm website, verified Aug 6, 2026.
Team · 2 people
from public directoriesWhat they invest in
from 4 of 5 portfolio companiesBiotech ×3Digital Health ×3Medical Devices ×3Deep Tech ×2Healthtech ×2Wellness & Fitness ×1
HQs:United States×4
Investments · 5 tracked
founders shown can be your intro pathBy year:2024 · 22021 · 24 dated
ANNA Autism Care provides ABA therapy for autistic children using Naturalistic Developmental Behavioral Intervention alongside parent coaching.
Digital HealthHealthtechWellness & FitnessBoston, US
Aimun Malik(Executive Officer, Director, Promoter)
BoardBinoy Bhansali(Director)Sean Doolan(Director)in
Co-investorsGreyMatterVirtue Ventures
Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.
BiotechDigital HealthMedical Devices
Co-investorsArtis VenturesCasa Verde CapitalNoeticOMX VenturesPsyMed VenturesRA Capital+6 more
Active seed-stage healthcare company
Eugene, US
Nicholas Allen(Chief Executive Officer)Phillip Scripa(Chief Financial Officer and Secretary)William Shortt(Chief Operating Officer)Jan Hardorp(Director)
Co-investorsBIP VenturesJLS
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)
BoardJacob Robinson(Co-founder & CEO)in
Co-investorsArboretum VenturesPsyMed VenturesTMC Venture FundXEIA Venture PartnersCapital FactoryDivergent Capital+3 more
Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.
BiotechDeep TechMedical DevicesCampbell, US
Thomas James Oxley(Executive Officer, Director)Nicholas Opie(Director)inThomas Oxley(Founder)in
BoardRahul Sharma(Director)Alex Morgan(Director)inMartin Dieck(Director)
Co-investorsARCH Venture PartnersForepont Capital PartnersID8 InvestmentsKaleida CapitalKhosla VenturesBezos Expeditions+4 more
Portfolio news
latest coverage across their companiesKsana Health · prnewswire.com · May 14, 2026
Anna Health · breakingnewsaba.com · May 14, 2026
Motif Neurotech · businesswire.com · Dec 16, 2025
Synchron · medtechdive.com · Nov 7, 2025
Delix · ucdavis.edu · Sep 10, 2025
Frequently asked questions
- What stage does re.Mind Capital invest at?
- re.Mind Capital invests at the Pre-Seed, Seed, Series A stages.
- What sectors does re.Mind Capital focus on?
- re.Mind Capital focuses on Healthtech, Mental Health, Wellness & Fitness.
- Where is re.Mind Capital located?
- re.Mind Capital is headquartered in London, GB.
Co-investors · 3
Founders Fund is a venture capital firm that backs technology companies building transformative products.
What If Ventures is a venture capital firm investing in transformative technology, with a focus on healthcare/mental health and defense technology.
Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.
Firms observed investing alongside re.Mind Capital, from public investor directories. Shared companies are the overlap with re.Mind Capital's recorded portfolio.
Similar investors
W Health Ventures is an investment firm and healthcare-focused venture studio that builds generational healthcare companies from scratch, primarily in India and the US.
Equitage Ventures is an early-stage investor providing capital, distribution, and strategic guidance to entrepreneurs addressing the physical, mental, spiritual, and social needs of older adults across the senior care continuum.
Social Starts is a group of early-stage venture funds that applies a data-driven, analytics-based methodology to identify and back promising companies in high-potential segments. Its current fund, Social Starts Health and Happiness, targets startups focused on helping people live longer and better.
Pave Health Ventures is an early-stage investor and company builder focused on health, backing founders from the ideation stage across products, technology, and tech-enabled services.
Wild Tree Ventures is an early-stage venture firm that backs founders addressing demographic change and longer lifespans through scalable innovation, and also offers its investment capabilities to external partners as a service.



